Orally Disintegrating Tablet Market Size & Share, By Type (Anti-Psychotics Drug, Anti-Epileptics Drug, Others), Application (CNS Disease, Gastrointestinal Disease, CVS Disease, Others) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 6019| Published Date: Jan-2025| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Orally Disintegrating Tablet Market size is set to increase from USD 15.68 billion in 2024 to USD 33.85 billion by 2034, with a projected CAGR exceeding 8% from 2025 to 2034. The industry revenue for 2025 is anticipated to hit USD 16.81 billion.

Base Year Value (2024)
USD 15.68 billion
CAGR (2025-2034)
8%
Forecast Year Value (2034)
USD 33.85 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Orally Disintegrating Tablet Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Market Dynamics

Market Growth Drivers and Industry Trends

Growth Drivers & Opportunity: The growing prevalence of chronic diseases and the increasing demand for quick and convenient drug delivery methods are major growth drivers for the orally disintegrating tablet market. Patients prefer ODTs over traditional pills due to ease of administration, especially for those who have difficulty swallowing. Additionally, the expanding geriatric population, who often struggle with swallowing tablets, is further driving the market's growth. The increasing R&D investments in developing innovative formulations and technologies for orally disintegrating tablets are propelling market growth. Pharmaceutical companies are focusing on enhancing the taste, stability, and bioavailability of ODTs to improve patient compliance and overall experience. Furthermore, the rise in partnerships and collaborations between drug manufacturers and technology providers is accelerating product development and market expansion. The rising adoption of self-medication and over-the-counter drugs is fueling the demand for orally disintegrating tablets, as they offer convenience and ease of use for consumers. ODTs provide a discreet and portable way for individuals to take medication without the need for water, making them ideal for on-the-go and emergency situations. This increasing trend in self-care practices is contributing to the market's growth potential. Industry Restraints: Stringent regulatory requirements and approval processes pose a significant challenge for players in the orally disintegrating tablet market. Meeting regulatory standards for safety, efficacy, and quality control can be time-consuming and costly, hindering the speed of product commercialization. Companies need to navigate complex regulatory landscapes to bring new ODT formulations to market, limiting growth opportunities. The high production costs associated with developing orally disintegrating tablets can restrain market growth, particularly for smaller pharmaceutical companies and startups. The specialized equipment and technologies required for manufacturing ODTs add to production expenses, impacting profit margins. Companies may face challenges in achieving economies of scale and cost-efficiency in ODT production, posing a barrier to market entry and expansion.

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Orally Disintegrating Tablet Market
Largest Region
North America
37% Market Share in 2024
North America: The Orally Disintegrating Tablet Market in North America is expected to witness significant growth due to increasing prevalence of chronic diseases and rising demand for convenient drug delivery methods in countries such as the U.S. and Canada. Asia Pacific: In Asia Pacific, countries like China, Japan, and South Korea are expected to contribute significantly to the growth of the Orally Disintegrating Tablet Market. Increasing geriatric population and rising healthcare expenditure in these countries are driving the demand for innovative drug delivery technologies. Europe: The Orally Disintegrating Tablet Market in Europe, particularly in countries like the United Kingdom, Germany, and France, is poised for substantial growth. Factors such as increasing adoption of advanced healthcare technologies and rising focus on patient-centric care are driving the market growth in the region.
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Orally Disintegrating Tablet Market Anti-Psychotics Drug: The segment analysis of orally disintegrating tablets market by type shows a significant presence of anti-psychotics drugs. These medications, used to treat mental health conditions like schizophrenia and bipolar disorder, are increasingly being formulated as orally disintegrating tablets for ease of administration and improved patient compliance. Anti-Epileptics Drug: Another key segment in the orally disintegrating tablet market is anti-epileptics drugs. These medications are vital in managing seizures and epilepsy, and the availability of orally disintegrating tablets provides a convenient option for patients who may have difficulty swallowing traditional tablets. Others: In addition to anti-psychotics and anti-epileptics drugs, the orally disintegrating tablet market also includes other types of medications. These may include drugs for various conditions such as allergies, pain management, and hormonal disorders, among others. The versatility of orally disintegrating tablets makes them a favorable dosage form for a wide range of therapeutic areas. CNS Disease: Among the various applications of orally disintegrating tablets, the segment analysis highlights a strong presence in the central nervous system (CNS) disease category. These include conditions like depression, anxiety, and Parkinson's disease, where the convenience and rapid onset of action offered by orally disintegrating tablets are particularly beneficial for patients. Gastrointestinal Disease: Orally disintegrating tablets are also making an impact in the treatment of gastrointestinal diseases. Medications for conditions like acid reflux, irritable bowel syndrome, and inflammatory bowel disease are being formulated as orally disintegrating tablets to cater to the specific needs of patients who may struggle with swallowing traditional tablets. CVS Disease: Cardiovascular disease, another key category in the segment analysis of orally disintegrating tablets, includes medications for conditions such as hypertension, heart failure, and high cholesterol. The use of orally disintegrating tablets in this area can help improve medication adherence and ensure better treatment outcomes for patients with cardiovascular diseases. Others: Aside from CNS, gastrointestinal, and cardiovascular diseases, orally disintegrating tablets are also being employed in the treatment of various other conditions. These may include respiratory diseases, endocrine disorders, and infectious diseases, among others. The versatility and convenience of orally disintegrating tablets make them a promising dosage form across a wide spectrum of healthcare applications.
Segment Sub-Segment Largest Segment Fastest Growing
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

The competitive landscape in the Orally Disintegrating Tablet Market is characterized by intense rivalry among key players striving to maintain their market position and gain a competitive edge through product innovation, strategic partnerships, and acquisitions. Some of the top players operating in the Orally Disintegrating Tablet Market across the world include: 1. Pfizer Inc. 2. Novartis AG 3. AstraZeneca 4. Merck & Co., Inc. 5. Teva Pharmaceutical Industries Ltd. 6. GlaxoSmithKline plc 7. Johnson & Johnson 8. Otsuka Holdings Co., Ltd. 9. Dr. Reddy's Laboratories Ltd. 10. Eli Lilly and Company
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Orally Disintegrating Tablet Market — Custom Segments

Segment Sub-Segment
No segment data available.

Orally Disintegrating Tablet Market — Custom TOC

Custom Chapter Chapter Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →